ERBB2 and breast carcinoma: Furthermore, the HER2-positive breast cancer is known to be more aggressive and resistant to medicinal treatment [7–9], implicating that improving the method of tumor destruction instead of changing anti-cancer drugs persistently may truly cure the HER2-positive breast cancer.